Contribution of lipopolysaccharide binding protein (LBP) in endotoxemic shock in mice.
Department of Medicine, CHUV-1011, Lausanne, Switzerland.
D
D
Heumann
P
P
Gallay
D
D
Le Roy
M P
MP
Glauser
D000209:Acute-Phase Proteins; D000818:Animals; D002352:Carrier Proteins / Q000037:antagonists & inhibitors / Q000276:immunology / Q000502:physiology*; D005688:Galactosamine / Q000494:pharmacology; D007074:Immunoglobulin G / Q000494:pharmacology; D066298:In Vitro Techniques; D008070:Lipopolysaccharides / Q000037:antagonists & inhibitors / Q000378:metabolism* / Q000633:toxicity; D008562:Membrane Glycoproteins; D051379:Mice; D009000:Monocytes / Q000502:physiology; D009500:Neutralization Tests; D009504:Neutrophils / Q000502:physiology; D012772:Shock, Septic / Q000378:metabolism* / Q000628:therapy; D014115:Toxemia / Q000378:metabolism* / Q000628:therapy; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism; D000099231:Lipopolysaccharide-Binding Protein
D000209:Acute-Phase Proteins; D002352:Carrier Proteins; D005688:Galactosamine; D007074:Immunoglobulin G; D008070:Lipopolysaccharides; D008562:Membrane Glycoproteins; D014409:Tumor Necrosis Factor-alpha; D000099231:Lipopolysaccharide-Binding Protein